CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- 4 Gift CEO and President gave 8,563 shares (gift)
- 4 Open-market sale 10% owner sold 11,396 shares at $2.44 ($27,828)
- 4 Open-market sale 10% owner sold 74,551 shares at an average $2.36 ($175,842)
- 4 Open-market sale 10% owner sold 8,288 shares at $2.12 ($17,598)
- 4 Open-market sale 10% owner sold 64,568 shares at an average $2.21 ($142,503)
- 4 Open-market sale 10% owner sold 12,725 shares at $2.26 ($28,734)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 15,054 shares at an average $2.92 ($44,008)
- 4 Open-market sale 10% owner sold 42,800 shares at an average $3.05 ($130,434)
- 4 Open-market sale 10% owner sold 70,885 shares at an average $3.25 ($230,326)
- 4 Open-market sale 10% owner sold 182,300 shares at an average $3.11 ($566,951)
- 4 Shares withheld for taxes CEO and President gave up 7,803 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 2,879 shares (to pay taxes)
Page 4 of 20 · 382 filings